Search research articles
Contact Us
Filters
Showing results (321-330 of 431) with videos related to
Page
of 44
Sort By:
Journal of Pediatric Surgery
|
April 1, 2026
Late complications of treatment for childhood pelvic sarcoma: A report from the Childhood Cancer Survivor Study (CCSS)
Andrew J Murphy, Yan Chen, Danielle B Cameron, et al.
Scientific Reports
|
March 16, 2021
High intraluminal pressure promotes vascular inflammation via caveolin-1
Danielle L Michell, Waled A Shihata, Karen L Andrews, et al.
Clinical & Translational Immunology
|
April 24, 2023
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis
Dragana Dragoljevic, Man Kit Sam Lee, Gerard Pernes, et al.
Nature Communications
|
November 27, 2019
Publisher Correction: An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence
Chang-Han Lee, Tae Hyun Kang, Ophélie Godon, et al.
Allergy
|
December 16, 2019
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
Audrey Le Floc'h, Jeanne Allinne, Kirsten Nagashima, et al.
Iscience
|
January 22, 2019
TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis
Siân P Cartland, Scott W Genner, Gonzalo J Martínez, et al.
Plos Genetics
|
March 4, 2024
Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse
Eriks Smagris, Lisa M Shihanian, Ivory J Mintah, et al.
The Journal of Clinical Investigation
|
May 5, 2022
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
Senem Aykul, Lily Huang, Lili Wang, et al.
Nature Cancer
|
June 6, 2022
A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma
Nikos Kourtis, Qingqing Wang, Bei Wang, et al.
The Journal of Clinical Investigation
|
May 24, 2008
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
Sergey V Shmelkov, Jason M Butler, Andrea T Hooper, et al.
Page
of 44
Search research articles
Search
Showing results (321-330 of 431) with videos related to
Sort By:
Page
of 44
Journal of Pediatric Surgery
|
April 1, 2026
Late complications of treatment for childhood pelvic sarcoma: A report from the Childhood Cancer Survivor Study (CCSS)
Andrew J Murphy, Yan Chen, Danielle B Cameron, et al.
Scientific Reports
|
March 16, 2021
High intraluminal pressure promotes vascular inflammation via caveolin-1
Danielle L Michell, Waled A Shihata, Karen L Andrews, et al.
Clinical & Translational Immunology
|
April 24, 2023
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis
Dragana Dragoljevic, Man Kit Sam Lee, Gerard Pernes, et al.
Nature Communications
|
November 27, 2019
Publisher Correction: An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence
Chang-Han Lee, Tae Hyun Kang, Ophélie Godon, et al.
Allergy
|
December 16, 2019
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
Audrey Le Floc'h, Jeanne Allinne, Kirsten Nagashima, et al.
Iscience
|
January 22, 2019
TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis
Siân P Cartland, Scott W Genner, Gonzalo J Martínez, et al.
Plos Genetics
|
March 4, 2024
Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse
Eriks Smagris, Lisa M Shihanian, Ivory J Mintah, et al.
The Journal of Clinical Investigation
|
May 5, 2022
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
Senem Aykul, Lily Huang, Lili Wang, et al.
Nature Cancer
|
June 6, 2022
A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma
Nikos Kourtis, Qingqing Wang, Bei Wang, et al.
The Journal of Clinical Investigation
|
May 24, 2008
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
Sergey V Shmelkov, Jason M Butler, Andrea T Hooper, et al.
Page
of 44